Cargando…
Assay-related differences in SuPAR levels: implications for measurement and data interpretation
Autores principales: | Vasbinder, Alexi, Raffield, Laura Marie, Gao, Yan, Engstrom, Gunnar, Quyyumi, Arshed Ali, Reiner, Alexander Paul, Reiser, Jochen, Hayek, Salim Salim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106999/ https://www.ncbi.nlm.nih.gov/pubmed/35567697 http://dx.doi.org/10.1007/s40620-022-01344-7 |
Ejemplares similares
-
Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort Study
por: Hayek, Salim S., et al.
Publicado: (2017) -
Sex Differences in Circulating Soluble Urokinase‐Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease
por: Mehta, Anurag, et al.
Publicado: (2020) -
suPAR: An Inflammatory Mediator for Kidneys
por: Sudhini, Yashwanth Reddy, et al.
Publicado: (2022) -
Reassessing the Reassessment of suPAR in Glomerular Disease
por: Meijers, Björn K. I., et al.
Publicado: (2015) -
Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
por: Rovina, Nikoletta, et al.
Publicado: (2020)